Literature DB >> 24816941

Delayed gadolinium-enhanced MRI of the meniscus (dGEMRIM) in patients with knee osteoarthritis: relation with meniscal degeneration on conventional MRI, reproducibility, and correlation with dGEMRIC.

Jasper van Tiel1, Gyula Kotek, Max Reijman, Pieter K Bos, Esther E Bron, Stefan Klein, Jan A N Verhaar, Gabriel P Krestin, Harrie Weinans, Edwin H G Oei.   

Abstract

OBJECTIVES: To assess (1) whether normal and degenerated menisci exhibit different T1GD on delayed gadolinium-enhanced MRI of the meniscus (dGEMRIM), (2) the reproducibility of dGEMRIM and (3) the correlation between meniscus and cartilage T1GD in knee osteoarthritis (OA) patients.
METHODS: In 17 OA patients who underwent dGEMRIM twice within 7 days, meniscus and cartilage T1GD was calculated. Meniscus pathology was evaluated on conventional MRI. T1GD in normal and degenerated menisci were compared using a Student's t-test. Reproducibility was assessed using ICCs. Pearson's correlation was calculated between meniscus and cartilage T1GD.
RESULTS: A trend towards lower T1GD in degenerated menisci (mean: 402 ms; 95% CI: 359-444 ms) compared to normal menisci (mean: 448 ms; 95% CI: 423-473 ms) was observed (p = 0.05). Meniscus T1GD ICCs were 0.85-0.90. The correlation between meniscus and cartilage T1GD was moderate in the lateral (r = 0.52-0.75) and strong in the medial compartment (r = 0.78-0.94).
CONCLUSIONS: Our results show that degenerated menisci have a clear trend towards lower T1GD compared to normal menisci. Since these results are highly reproducible, meniscus degeneration may be assessed within one delayed gadolinium-enhanced MRI simultaneously with cartilage. The strong correlation between meniscus and cartilage T1GD suggests concomitant degeneration in both tissues in OA, but also suggests that dGEMRIC may not be regarded entirely as sulphated glycosaminoglycan specific. KEY POINTS: dGEMRIM T1 GD can possibly be used to assess meniscal degeneration; dGEMRIM yields highly reproducible meniscal T1 GD in early stage osteoarthritic patients; Concomitant degeneration of cartilage and meniscus tissue occurs in early stage osteoarthritis; dGEMRIC cannot be regarded as entirely sulphated glycosaminoglycan specific.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24816941     DOI: 10.1007/s00330-014-3204-z

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  44 in total

1.  Radiological assessment of osteo-arthrosis.

Authors:  J H KELLGREN; J S LAWRENCE
Journal:  Ann Rheum Dis       Date:  1957-12       Impact factor: 19.103

Review 2.  Statistical methods for assessing measurement error (reliability) in variables relevant to sports medicine.

Authors:  G Atkinson; A M Nevill
Journal:  Sports Med       Date:  1998-10       Impact factor: 11.136

3.  T2 relaxation reveals spatial collagen architecture in articular cartilage: a comparative quantitative MRI and polarized light microscopic study.

Authors:  M T Nieminen; J Rieppo; J Töyräs; J M Hakumäki; J Silvennoinen; M M Hyttinen; H J Helminen; J S Jurvelin
Journal:  Magn Reson Med       Date:  2001-09       Impact factor: 4.668

4.  Nondestructive imaging of human cartilage glycosaminoglycan concentration by MRI.

Authors:  A Bashir; M L Gray; J Hartke; D Burstein
Journal:  Magn Reson Med       Date:  1999-05       Impact factor: 4.668

5.  Delayed gadolinium-enhanced MRI of cartilage (dGEMRIC) in early knee osteoarthritis.

Authors:  Carl Johan Tiderius; Lars E Olsson; Peter Leander; Olle Ekberg; Leif Dahlberg
Journal:  Magn Reson Med       Date:  2003-03       Impact factor: 4.668

6.  Early changes in lapine menisci during osteoarthritis development: Part I: cellular and matrix alterations.

Authors:  M P Hellio Le Graverand; E Vignon; I G Otterness; D A Hart
Journal:  Osteoarthritis Cartilage       Date:  2001-01       Impact factor: 6.576

7.  Delayed gadolinium-enhanced MR to determine glycosaminoglycan concentration in reparative cartilage after autologous chondrocyte implantation: preliminary results.

Authors:  Atsuya Watanabe; Yuichi Wada; Takayuki Obata; Takuya Ueda; Mitsuru Tamura; Hiroo Ikehira; Hideshige Moriya
Journal:  Radiology       Date:  2006-02-16       Impact factor: 11.105

8.  Delayed gadolinium-enhanced magnetic resonance imaging of the meniscus: an index of meniscal tissue degeneration?

Authors:  Nitya Krishnan; Sanjay K Shetty; Ashley Williams; Brandon Mikulis; Charles McKenzie; Deborah Burstein
Journal:  Arthritis Rheum       Date:  2007-05

9.  Bath Concentration of Anionic Contrast Agents Does Not Affect Their Diffusion and Distribution in Articular Cartilage In Vitro.

Authors:  Tuomo S Silvast; Jukka S Jurvelin; Virpi Tiitu; Thomas M Quinn; Juha Töyräs
Journal:  Cartilage       Date:  2013-01       Impact factor: 4.634

10.  Image registration improves human knee cartilage T1 mapping with delayed gadolinium-enhanced MRI of cartilage (dGEMRIC).

Authors:  Esther E Bron; Jasper van Tiel; Henk Smit; Dirk H J Poot; Wiro J Niessen; Gabriel P Krestin; Harrie Weinans; Edwin H G Oei; Gyula Kotek; Stefan Klein
Journal:  Eur Radiol       Date:  2012-08-04       Impact factor: 5.315

View more
  3 in total

1.  MR T1ρ and T2 of meniscus after acute anterior cruciate ligament injuries.

Authors:  Amy Wang; Valentina Pedoia; Favian Su; Elijah Abramson; Martin Kretzschmar; Lorenzo Nardo; Thomas M Link; Charles E McCulloch; Chengshi Jin; C Benjamin Ma; Xiaojuan Li
Journal:  Osteoarthritis Cartilage       Date:  2015-12-02       Impact factor: 6.576

2.  The Glycosaminoglycan Content of Hip Cartilage in Osteonecrosis of Femoral Head: Evaluation with Delayed Gadolinium-Enhanced Magnetic Resonance Imaging of Cartilage.

Authors:  Qidong Zhang; Wanshou Guo; Yan Chen; Qichao Zhao; Zhaohui Liu; Weiguo Wang
Journal:  Cartilage       Date:  2018-10-03       Impact factor: 4.634

3.  Delayed gadolinium-enhanced MRI of meniscus (dGEMRIM) and cartilage (dGEMRIC) in healthy knees and in knees with different stages of meniscus pathology.

Authors:  Ulf Sigurdsson; Gunilla Müller; Carl Siversson; Eveliina Lammentausta; Jonas Svensson; Carl-Johan Tiderius; Leif E Dahlberg
Journal:  BMC Musculoskelet Disord       Date:  2016-09-29       Impact factor: 2.362

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.